• OPEN AN ACCOUNT
Indian Indices
Sensex
72,634.28 -137.44
( -0.19%)
Global Indices
Nasdaq
51,510.98 -338.64
(-0.65%)
Dow Jones
7,705.40 -59.01
(-0.76%)
Hang Seng
66,234.37 -129.83
(-0.20%)
Nikkei 225
10,700.56 5.31
(0.05%)
Forex
USD-INR
95.89 0.16
(0.16%)
EUR-INR
109.08 -0.12
(-0.11%)
GBP-INR
126.82 -0.30
(-0.24%)
JPY-INR
0.60 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Biocon Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532523
INE376G01013
167.9878498
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BIOCON
202.7
61113.53
EPS(TTM)
Face Value()
Div & Yield %
1.85
5
0.13
 

Gillette India standalone net profit rises 21.32% in the March 2026 quarter
May 27,2026
Net profit of Gillette India rose 21.32% to Rs 192.51 crore in the quarter ended March 2026 as against Rs 158.68 crore during the previous quarter ended March 2025. Sales rose 3.20% to Rs 792.00 crore in the quarter ended March 2026 as against Rs 767.47 crore during the previous quarter ended March 2025.

For the full year,net profit rose 56.66% to Rs 654.31 crore in the year ended March 2026 as against Rs 417.66 crore during the previous year ended March 2025. Sales rose 38.69% to Rs 3099.53 crore in the year ended March 2026 as against Rs 2234.84 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales792.00767.47 3 3099.532234.84 39
OPM %35.0129.42 -30.4326.80 -
PBDT278.96234.29 19 958.88618.43 55
PBT260.05209.76 24 880.34554.15 59
NP192.51158.68 21 654.31417.66 57